Cargando…

Steroid Induced Central Serous Chorioretinopathy in Giant Cell Arteritis

Giant cell arteritis (GCA) is an ophthalmic emergency which requires early diagnosis and treatment with high dose systemic corticosteroids in order to prevent permanent visual loss. However, systemic corticosteroids have significant ocular side effects including cataract formation, raised intraocula...

Descripción completa

Detalles Bibliográficos
Autores principales: Grixti, Andre, Kumar, Vineeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693111/
https://www.ncbi.nlm.nih.gov/pubmed/23840998
http://dx.doi.org/10.1155/2013/924037
_version_ 1782274706863292416
author Grixti, Andre
Kumar, Vineeth
author_facet Grixti, Andre
Kumar, Vineeth
author_sort Grixti, Andre
collection PubMed
description Giant cell arteritis (GCA) is an ophthalmic emergency which requires early diagnosis and treatment with high dose systemic corticosteroids in order to prevent permanent visual loss. However, systemic corticosteroids have significant ocular side effects including cataract formation, raised intraocular pressure, and less commonly, central serous chorioretinopathy (CSCR). We report a case of visual loss secondary to CSCR complicating corticosteroid therapy in GCA. When assessing patients with systemic conditions such as GCA or other vasculitic process, who complain of visual loss which is getting worse on corticosteroid treatment, clinicians should consider other causes such as CSCR as part of the differential diagnosis. Extra caution should be exercised in such cases as increasing the dose of corticosteroids might aggravate CSCR resulting in further visual loss.
format Online
Article
Text
id pubmed-3693111
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36931112013-07-09 Steroid Induced Central Serous Chorioretinopathy in Giant Cell Arteritis Grixti, Andre Kumar, Vineeth Case Rep Ophthalmol Med Case Report Giant cell arteritis (GCA) is an ophthalmic emergency which requires early diagnosis and treatment with high dose systemic corticosteroids in order to prevent permanent visual loss. However, systemic corticosteroids have significant ocular side effects including cataract formation, raised intraocular pressure, and less commonly, central serous chorioretinopathy (CSCR). We report a case of visual loss secondary to CSCR complicating corticosteroid therapy in GCA. When assessing patients with systemic conditions such as GCA or other vasculitic process, who complain of visual loss which is getting worse on corticosteroid treatment, clinicians should consider other causes such as CSCR as part of the differential diagnosis. Extra caution should be exercised in such cases as increasing the dose of corticosteroids might aggravate CSCR resulting in further visual loss. Hindawi Publishing Corporation 2013 2013-06-11 /pmc/articles/PMC3693111/ /pubmed/23840998 http://dx.doi.org/10.1155/2013/924037 Text en Copyright © 2013 A. Grixti and V. Kumar. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Grixti, Andre
Kumar, Vineeth
Steroid Induced Central Serous Chorioretinopathy in Giant Cell Arteritis
title Steroid Induced Central Serous Chorioretinopathy in Giant Cell Arteritis
title_full Steroid Induced Central Serous Chorioretinopathy in Giant Cell Arteritis
title_fullStr Steroid Induced Central Serous Chorioretinopathy in Giant Cell Arteritis
title_full_unstemmed Steroid Induced Central Serous Chorioretinopathy in Giant Cell Arteritis
title_short Steroid Induced Central Serous Chorioretinopathy in Giant Cell Arteritis
title_sort steroid induced central serous chorioretinopathy in giant cell arteritis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693111/
https://www.ncbi.nlm.nih.gov/pubmed/23840998
http://dx.doi.org/10.1155/2013/924037
work_keys_str_mv AT grixtiandre steroidinducedcentralserouschorioretinopathyingiantcellarteritis
AT kumarvineeth steroidinducedcentralserouschorioretinopathyingiantcellarteritis